You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Infectious Disease Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 3 of 3

A randomized multi-center study to evaluate the safety and efficacy of a study drug in subjects with severe sepsis

The purpose of this study is to evaluate the safety and potential efficacy signal of the study drug, BMS-936559, in subjects with severe sepsis.

Tidswell, Mark, MD
Infection

Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199

GEMINI 1 - A Phase III multicenter trial evaluating the efficacy, safety, and tolerability of dolutegravir plus lamivudine (study drugs) compared to dolutegravir plus tenofovir/emtricitabine in HIV-1

The purpose of this study is to compare safety, efficacy, and tolerability of a two drug regimen of dolutegravir (DTG) plus (+) lamivudine (3TC) administered once daily to the DTG plus Tenofovir [TDF]/Emtricitabine [FTC] fixed dose combination [FDC] administered once daily in human immunodeficiency virus (HIV) 1 infected adult subjects that have not previously received antiretroviral therapy. The study is designed to demonstrate the non-inferior antiviral activity of DTG plus 3TC regimen to that of DTG plus TDF/FTC FDC.
Dr. Daniel Skiest
Infection, HIV

Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199

INSIGHT Genomics Study to collect DNA of people with the flu

The purpose of this study is to obtain DNA of people who may have the flu in order to better understand the gene response to those that have a high risk of getting the flu.

Armando Paez, MD
Infection

Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199

Page 1 of 1 | Results 1 - 3 of 3